BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32878131)

  • 1. PIM1 Promotes Survival of Cardiomyocytes by Upregulating c-Kit Protein Expression.
    Ebeid DE; Firouzi F; Esquer CY; Navarrete JM; Wang BJ; Gude NA; Sussman MA
    Cells; 2020 Aug; 9(9):. PubMed ID: 32878131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pim-1 Kinase Phosphorylates Cardiac Troponin I and Regulates Cardiac Myofilament Function.
    Zhu N; Yi B; Guo Z; Zhang G; Huang S; Qin Y; Zhao X; Sun J
    Cell Physiol Biochem; 2018; 45(6):2174-2186. PubMed ID: 29544221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pim1 maintains telomere length in mouse cardiomyocytes by inhibiting TGFβ signalling.
    Ebeid DE; Khalafalla FG; Broughton KM; Monsanto MM; Esquer CY; Sacchi V; Hariharan N; Korski KI; Moshref M; Emathinger J; Cottage CT; Quijada PJ; Nguyen JH; Alvarez R; Völkers M; Konstandin MH; Wang BJ; Firouzi F; Navarrete JM; Gude NA; Goumans MJ; Sussman MA
    Cardiovasc Res; 2021 Jan; 117(1):201-211. PubMed ID: 32176281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pim1 Overexpression Prevents Apoptosis in Cardiomyocytes After Exposure to Hypoxia and Oxidative Stress via Upregulating Cell Autophagy.
    Zhu HH; Wang XT; Sun YH; He WK; Liang JB; Mo BH; Li L
    Cell Physiol Biochem; 2018; 49(6):2138-2150. PubMed ID: 30257237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
    Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
    Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.
    An N; Lin YW; Mahajan S; Kellner JN; Wang Y; Li Z; Kraft AS; Kang Y
    Stem Cells; 2013 Jun; 31(6):1202-12. PubMed ID: 23495171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells.
    Broughton K; Korski K; Echeagaray O; Adamson R; Dembitsky W; Lu Z; Schaefer E; Sussman MA
    Gene Ther; 2019 Aug; 26(7-8):324-337. PubMed ID: 31239537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim1 kinase regulates c-Kit gene translation.
    An N; Cen B; Cai H; Song JH; Kraft A; Kang Y
    Exp Hematol Oncol; 2016; 5():31. PubMed ID: 28042518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.
    Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS
    Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac c-Kit Biology Revealed by Inducible Transgenesis.
    Gude NA; Firouzi F; Broughton KM; Ilves K; Nguyen KP; Payne CR; Sacchi V; Monsanto MM; Casillas AR; Khalafalla FG; Wang BJ; Ebeid DE; Alvarez R; Dembitsky WP; Bailey BA; van Berlo J; Sussman MA
    Circ Res; 2018 Jun; 123(1):57-72. PubMed ID: 29636378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIM1-minicircle as a therapeutic treatment for myocardial infarction.
    Liu N; Wang BJ; Broughton KM; Alvarez R; Siddiqi S; Loaiza R; Nguyen N; Quijada P; Gude N; Sussman MA
    PLoS One; 2017; 12(3):e0173963. PubMed ID: 28323876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-kit is required for cardiomyocyte terminal differentiation.
    Li M; Naqvi N; Yahiro E; Liu K; Powell PC; Bradley WE; Martin DI; Graham RM; Dell'Italia LJ; Husain A
    Circ Res; 2008 Mar; 102(6):677-85. PubMed ID: 18258857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.
    Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A
    PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
    Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
    Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pim-1 regulates cardiomyocyte survival downstream of Akt.
    Muraski JA; Rota M; Misao Y; Fransioli J; Cottage C; Gude N; Esposito G; Delucchi F; Arcarese M; Alvarez R; Siddiqi S; Emmanuel GN; Wu W; Fischer K; Martindale JJ; Glembotski CC; Leri A; Kajstura J; Magnuson N; Berns A; Beretta RM; Houser SR; Schaefer EM; Anversa P; Sussman MA
    Nat Med; 2007 Dec; 13(12):1467-75. PubMed ID: 18037896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
    Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
    Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear PIM1 confers resistance to rapamycin-impaired endothelial proliferation.
    Walpen T; Kalus I; Schwaller J; Peier MA; Battegay EJ; Humar R
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):24-30. PubMed ID: 23131564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.
    Blanco FF; Jimbo M; Wulfkuhle J; Gallagher I; Deng J; Enyenihi L; Meisner-Kober N; Londin E; Rigoutsos I; Sawicki JA; Risbud MV; Witkiewicz AK; McCue PA; Jiang W; Rui H; Yeo CJ; Petricoin E; Winter JM; Brody JR
    Oncogene; 2016 May; 35(19):2529-41. PubMed ID: 26387536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.